Nastasi, N.; Pasha, A.; Bruno, G.; Subbiani, A.; Pietrovito, L.; Leo, A.; Scala, L.; de Simone, L.; Casazza, G.; Lunardi, F.;
et al. Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma. Cancers 2023, 15, 4744.
https://doi.org/10.3390/cancers15194744
AMA Style
Nastasi N, Pasha A, Bruno G, Subbiani A, Pietrovito L, Leo A, Scala L, de Simone L, Casazza G, Lunardi F,
et al. Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma. Cancers. 2023; 15(19):4744.
https://doi.org/10.3390/cancers15194744
Chicago/Turabian Style
Nastasi, Nicoletta, Amada Pasha, Gennaro Bruno, Angela Subbiani, Laura Pietrovito, Angela Leo, Lucia Scala, Lorena de Simone, Gabriella Casazza, Federica Lunardi,
and et al. 2023. "Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma" Cancers 15, no. 19: 4744.
https://doi.org/10.3390/cancers15194744
APA Style
Nastasi, N., Pasha, A., Bruno, G., Subbiani, A., Pietrovito, L., Leo, A., Scala, L., de Simone, L., Casazza, G., Lunardi, F., Taddei, M. L., Tamburini, A., Tondo, A., Favre, C., & Calvani, M.
(2023). Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma. Cancers, 15(19), 4744.
https://doi.org/10.3390/cancers15194744